Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors
- PMID: 15257044
- DOI: 10.1097/01.tp.0000132327.40702.97
Assessment of optimal size and composition of the U.S. National Registry of hematopoietic stem cell donors
Abstract
Background: The National Marrow Donor Program (NMDP) receives federal funding to operate a registry of over 4 million volunteer donors for patients in need of a hematopoietic stem cell transplant. Because minority patients are less likely to find a suitably matched donor than whites, special efforts have been aimed toward recruitment of minorities. Significant financial resources are required to recruit and tissue type additional volunteer donors.
Methods: Population genetics models have been constructed to project likelihoods of finding a human leukocyte antigen (HLA)-matched donor for patients of various racial/ethnic groups. These projections have been made under a variety of strategies for expansion of the NMDP Registry. Cost-effectiveness calculations incorporated donor unavailability and other barriers to transplantation.
Results: At current recruitment rates, the probability of an available HLA-A,B,DRB1 matched donor is projected to increase from 27% to 34%; 45% to 54%; 75% to 79%; and 48% to 55%, for blacks, Asians/Pacific Islanders, whites and Hispanics, respectively, by the year 2007. Substantial increases in minority recruitment would have only modest impacts on these projections. These projections are heavily affected by donor availability rates, which are less than 50% for minority volunteers.
Conclusions: Continued recruitment of additional volunteers can improve the likelihood of finding an HLA-matched donor, but will still leave significant numbers of patients of all racial/ethnic groups without a match. Efforts to improve donor availability (especially among minorities) and to increase the number of patients with access to the NMDP Registry may prove to be more cost-effective means of increasing transplants.
Similar articles
-
HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.N Engl J Med. 2014 Jul 24;371(4):339-48. doi: 10.1056/NEJMsa1311707. N Engl J Med. 2014. PMID: 25054717 Free PMC article.
-
Efforts of the United States' National Marrow Donor Program and Registry to improve utilization and representation of minority donors.Transfus Med. 2008 Aug;18(4):250-9. doi: 10.1111/j.1365-3148.2008.00865.x. Transfus Med. 2008. PMID: 18783584 Review.
-
The National Marrow Donor Program: improving access to hematopoietic cell transplantation.Clin Transpl. 2011:55-62. Clin Transpl. 2011. PMID: 22755401
-
The National Marrow Donor Program: improving access to hematopoietic stem cell transplantation.Clin Transpl. 1999:121-7. Clin Transpl. 1999. PMID: 11038630
-
Effect of HLA incompatibility in marrow transplantation from unrelated and HLA-mismatched related donors.Transfus Sci. 1994 Sep;15(3):221-30. doi: 10.1016/0955-3886(94)90134-1. Transfus Sci. 1994. PMID: 10155543 Review.
Cited by
-
The heterogeneous HLA genetic makeup of the Swiss population.PLoS One. 2012;7(7):e41400. doi: 10.1371/journal.pone.0041400. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848484 Free PMC article.
-
Race and ethnicity in decisions about unrelated hematopoietic stem cell donation.Blood. 2013 Feb 21;121(8):1469-76. doi: 10.1182/blood-2012-06-437343. Epub 2012 Dec 20. Blood. 2013. PMID: 23258921 Free PMC article.
-
High-resolution analysis of the HLA-A, -B, -C and -DRB1 alleles and national and regional haplotype frequencies based on 120 926 volunteers from the Italian Bone Marrow Donor Registry.HLA. 2019 Sep;94(3):285-295. doi: 10.1111/tan.13613. Epub 2019 Jul 3. HLA. 2019. PMID: 31207125 Free PMC article. Clinical Trial.
-
Regenerative Medicine: Case Study for Understanding and Anticipating Emerging Science and Technology.NAM Perspect. 2023 Nov 15;2023:10.31478/202311d. doi: 10.31478/202311d. eCollection 2023. NAM Perspect. 2023. PMID: 38855738 Free PMC article. Review. No abstract available.
-
Effectiveness of partner social support predicts enduring psychological distress after hematopoietic stem cell transplantation.J Consult Clin Psychol. 2011 Feb;79(1):64-74. doi: 10.1037/a0022199. J Consult Clin Psychol. 2011. PMID: 21261435 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials